The role of MCP-1 in atherosclerosis

Stem Cells

Volumn 18, Issue 1, 2000, Pages 65-66

  Harrington, Jennifer R ^a  

^a R and D Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; INFLAMMATORY CELL; MOUSE; NONHUMAN; PATHOGENESIS; SHORT SURVEY;

ANIMALIA;

EID: 0033956625     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.18-1-65     Document Type: Short Survey

References (8)

1. Takeya M et al. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Human Pathol 1993;5:534-539.
2. Nelken NA et al. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;4:1121-1127.
3. Yla-Herttuala S et al. Expression of monocyte chemoattractant protein-1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991;88:5252-5256.
4. Seino Y et al. Expression of monocyte chemoattractant protein-1 in vascular tissue. Cytokine 1995;6:575-579.
5. Schwanz CJ et al. The pathogenesis of atherosclerosis: an overview. Clin Cardiol 1991;2(suppl 1):I1-I16.
6. Taub DD, Chemokine-leukocyte interactions. The voodoo that they do so well. Cytokine Growth Factor Rev 1996;7:355-376.
7. Gu L et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-281.
8. + mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998;394:894-897.